Introduction
Chronic immune activation and homeostatic disturbance of T cell subsets that accompany viral replication are hallmarks of HIV-1 infection [1] [2] [3] [4] . The cause and implications of these profound quantitative and qualitative changes in CD4 þ memory T cell subsets during HIV-1 infection are still not well understood [2] . Elucidating the causal relationships between perturbed naïve and memory T cell compartments during the course of HIV-1 infection could be critical in understanding its pathogenesis. Human T cells are categorized as naïve (T N ) and memory (T M ) subsets based on expression of CD45RA and CD45RO isoforms, respectively [5] [6] [7] [8] . It is now known that memory T cells are comprised of distinct subsets that can be identified based on other surface markers and effector functions [9] . Sallusto and colleagues defined two CD4 þ memory T cell subsets, termed central memory (T CM ) and effector memory (T EM ) cells [8] . T EM cells have low expression levels of the chemokine receptor CCR7 and lymph node homing receptor CD62L, express receptors for migration to inflamed tissues, and display immediate effector functions [8, 10] . In contrast, T CM cells express high levels of CCR7 and lack potent effector functions. It has been proposed that T CM cells are responsible for maintaining long-term memory, and upon re-exposure to antigens, differentiate into T EM cells with effector functions. Prior studies indicated that HIV-1 preferentially infects memory, rather than naïve CD4 þ T cells [11] [12] [13] [14] [15] [16] , possibly because of exclusive expression of the HIV-1 coreceptor CCR5 on memory T cells. Within the memory population, T EM cells are enriched for expression of CCR5 relative to other CD4 memory cells [17, 18] , suggesting that they may be primary targets for CCR5-tropic (R5-tropic) viruses that predominate in most infected persons.
Because chronic HIV-1 infection disrupts the balance between naïve and memory T cell subsets [19] , we characterized the distribution of these cells during HIV-1 infection. We found that a small subset of CD4 þ T EM cells, which we called CD4 þ T EMRA cells, were greatly increased in some HIV-infected individuals relative to uninfected individuals. Remarkably, CD4 þ T EMRA cells displayed a specific post-entry block to R5-tropic HIV-1, despite expressing high levels of CCR5. Accumulation of this effector memory CD4 þ T cell subset during chronic HIV infection could have important implications in understanding intrinsic resistance to the virus and perturbation of T cell compartments in infected individuals. 
Results

Human T Cell Subset Distribution during HIV-1 Infection
Phenotypic Characterization of CD4 þ T EMRA Cells
The high proportion of T EMRA cells found in HIV-infected individuals prompted further analysis of this subset. We hypothesized that T EMRA cells are a subset of effector memory CD4 þ T cells, analogous to a subset recently described for CD8 þ T cells with the same surface marker phenotype [20] .
The four subsets of CD4 þ T cells (T N , T CM , T EMRO , and T EMRA ) obtained from HIV-infected and HIV-uninfected individuals were analyzed for expression of cell surface molecules known to be expressed differentially in naïve, memory, and effector T cells. All T N cells expressed CD28, CD27, CD7, and CD62L, with progressively less expression on CD4 þ T CM , T EMRO , and T EMRA cells (Figure 2 ). In contrast, expression of CD11b, CD57, and HLA-DR were increased on T EMRO and T EMRA cells compared to CD4 þ T N and T CM cells (Figure 2 ). In contrast to T CM and T EMRO cells, T EMRA cells also expressed high levels of CD45RA, similar to T N cells (Figure 2, top panel 
Proliferative Capacity and Apoptosis of Effector Memory T Cell Subsets
Differentiated effector memory T cells have a reduced proliferative capacity [8, 20] . To assess the relative proliferative capacity of the different CD4 þ T cell subsets, each subset was purified from an HIV-uninfected individual according to CCR7 and CD45RO expression as shown in Figure 1A , and stimulated with dendritic cells (DCs) pulsed with superantigen (staphylococcal enterotoxin B [SEB]). Activated T cells were counted at day 12 ( Figure 3A ). DC-mediated activation caused robust cell division of T N and T CM cells ( Figure 3A ), whereas T EMRO cells and T EMRA cells divided fewer times ( Figure 3A) . The reduced proliferative capacity of effector T cells correlates with a decrease in telomere length and with an increased propensity to undergo apoptosis [9] . To determine whether T EMRA cells undergo apoptosis similar to effector T cells, all T cell subsets were stained with a marker of apoptosis (Annexin V) before and after cells were stimulated through the T cell receptor (TCR) by anti-CD3 plus anti-CD28 antibodies for 18 h. A higher proportion of effector T cells underwent apoptosis compared to T N and T CM cells ( Figure  3B ). Levels of apoptosis were comparable between T EMRO and T EMRA cells before and after TCR stimulation ( Figure 3B ).
Cytokine Profile of Human Effector Memory T Cells
A hallmark of T EM cells is secretion of greater quantities of cytokines when stimulated through the TCR, as compared to T N and T CM cells [8, 10] . We therefore explored cytokine profiles of T EMRO and T EMRA subsets. As expected, [8, 10] T EMRO cells secreted greater amounts of most cytokines assayed (IL-4, IL-5, IL-10, TNF-a, and IFN-c) compared to T N and T CM cells ( Figure 3C ). T EMRA cells secreted high levels of IFN-c, but much lower levels of IL-4, IL-5, or IL-10 compared to T EMRO cells ( Figure 3C ). This cytokine profile suggested that the T EMRA subset is skewed towards a Th1 phenotype. Recently, a cell surface molecule called CRTH2 was shown to be highly expressed on Th2 but not on Th1 cells [21] . To confirm Th1 skewing of T EMRA cells, we analyzed the surface expression of CRTH2. In agreement with the cytokine profile, significantly fewer T EMRA cells expressed CRTH2 compared to T EMRO or T CM subsets ( Figure S1 ). Taken together, we conclude that T EMRA cells are differentiated effector memory T cells that are skewed toward a Th1 phenotype.
HIV-1 Infection of TCR-Stimulated CD4
þ T Cell Subsets 
Author Summary
HIV-1 infection profoundly perturbs the immune system and is characterized by depletion of CD4 þ T cells and chronic immune activation, which lead to AIDS. Although HIV-1 targets CD4 þ T cells, it also requires a second receptor in order to infect the target cells. The majority of HIV-1 strains that are transmitted use a cell surface molecule called CCR5, which is expressed on a portion of T cells. In this manuscript we identify a subset of human CD4
þ T cells, which we termed T EMRA cells, that express CCR5 but still remain resistant to infection. We show that HIV-1 infection is blocked in T EMRA cells after entry of the virus, but before it has a chance to integrate into the cellular genome. T EMRA cells are present at low frequency in HIV-1 uninfected individuals but greatly increase in some HIV-infected individuals, which correlates with higher CD4 þ T cell numbers. These findings provide the basis for future studies to understand the role of T EMRA cells during HIV-1 infection and identify the host factors that could restrict the virus. This knowledge may be used to endow susceptible T cells with the ability to resist infection and result in novel vaccine or therapeutic strategies against HIV-1 infection. þ T cell subsets were analyzed in HIV-uninfected and HIV-infected individuals. Between 300,000 and 500,000 events were collected for each sample, and electronic gates were set on CD4 replication and are pseudotyped with vesicular stomatitis virus glycoprotein G (VSV-G.HIV). Each virus used here encoded green fluorescent protein (GFP) that was used to quantify infection by flow cytometry at specific time points after inoculation [22] .
cells. Distribution and median percentages of T N (CD45RO
Prior to the infectivity assay, we analyzed the expression of HIV-1 co-receptors CCR5 and CXCR4 on T N , T CM , T EMRO , and T EMRA cells isolated from an HIV-uninfected individual ( Figure 4A ). T EMRA and T EMRO cells expressed the highest levels of CCR5, while all four subsets expressed high levels of CXCR4 ( Figure 4A ). In addition, the median CCR5 expression was quantitated from 20 HIV-infected individuals, and the similar subset expression trends were confirmed ( Figure S2 ). When each T cell subset isolated from an HIV-uninfected individual was challenged with R5.HIV, CD4 T CM and T EMRO cells were more susceptible to infection than T N cells ( Figure  4B ), most likely reflecting high CCR5 surface expression levels on these memory T cells ( Figure 4A ). In contrast, T EMRA cells were resistant to a high multiplicity challenge with R5.HIV ( Figure 4B , top panel). This was an unexpected finding given the high cell surface CCR5 levels on T EMRA cells ( Figure 4A ). At day 12 post-infection, R5.HIV spread through the cultures, producing more infected T N , T CM , and T EMRO cells as compared to 5 d post-infection. Even at this late time point, T EMRA cells remained almost completely refractory to infection ( Figure 4B , second panel). In contrast, T EMRA cells were similarly susceptible to infection with X4.HIV, as well as other T cell subsets ( Figure 4B, third panel) . Surprisingly, T EMRA cells were also 5-to 10-fold less susceptible to VSV-G.HIV infection than other T cell subsets ( Figure 4B , bottom panel).
We then sought to determine whether over time the T EMRA subset would progressively become more susceptible to infection post-activation, or whether these cells were being killed in culture by rapidly replicating virus. For this experiment, T cells were infected with R5.HIV or X4.HIV for 2 d at different multiplicities of infection (MOIs) and then washed to remove input virus. Infection was quantified based on GFP expression at different time points after inoculation ( Figure 5A ), and viral replication was assessed by quantifying HIV p24 protein in culture supernatants. R5.HIV replicated efficiently in T N , T CM , and T EMRO cells, but there was little or no replication in T EMRA cells ( Figure 5B ). In contrast, X4.HIV infected and replicated efficiently in all four subsets and rapidly killed most of the T cells ( Figure 5A and 5B, right panels; unpublished data). Similar results were observed when primary HIV-1 isolates, utilizing different R5-tropic, X4-tropic, and R5X4-dual tropic HIV-1 envelopes that also express nef, were used ( Figure 5C ). The infectivity of T EMRA cells activated with SEB-pulsed DCs also remained identical (unpublished data).
The surface marker CD57 identifies terminally differentiated cells [23] , and expansion of CD57 þ cells occurs in HIV-infected individuals [24] . Because T EMRA cells were enriched in CD57 þ cells (Figure 2 ), we asked whether CD57 þ T cells were differentially susceptible to R5-tropic or X4-tropic viruses. For this experiment, T EMRA and T EMRO cells were further subdivided into CD57 þ and CD57 À subsets by flow cytometry cell sorting. Both CD57 þ and CD57 À subsets of T EMRA cells were resistant to infection by R5-tropic virus, whereas both CD57 þ and CD57 À subsets of T EMRO cells remained susceptible to R5-tropic virus infection ( Figure 6 , top panel). However, the CD57 þ and CD57 À subsets of both T EMRO and T EMRA cells were similarly susceptible to X4-tropic viruses ( Figure 6 , bottom panel). Thus, the relative resistance of T EMRA cells to R5-tropic HIV was not attributable to enrichment with the CD57 þ subset.
We next investigated where in the HIV-1 life cycle R5-tropic infection of T EMRA cells was blocked. Because large numbers of cells were required for these experiments, we expanded T N , T CM , T EMRO , and T EMRA cells purified from PBMCs of HIV-uninfected individuals using SEB-pulsed DCs for 12 d in IL-2-containing medium. In order to verify that CCR5 expression levels were maintained on expanded T cell subsets and that T EMRA cells remained resistant to R5-tropic infection, CCR5 expression was determined post-activation and expansion ( Figure 7A, top panel) . The expanded subsets Purified CD4 þ T cells were stained with CD45RO and CCR7 in conjunction with the antibodies shown. Electronic gates were set on T N , T CM , T EMRO , and T EMRA cells as described in Figure 1A , and expression of various T cell surface markers was analyzed. A representative profile from an HIVinfected individual is shown. Similar phenotype was observed in all four subsets of T cells from six HIV-infected and HIV-uninfected individuals. doi:10.1371/journal.ppat.0030058.g002
were then reactivated with SEB-pulsed DCs and subsequently infected with R5.HIV. Although the T EMRA cells maintained very high CCR5 expression, they remained resistant to R5-tropic infection ( Figure 7A, bottom panel) .
We first asked whether the block of R5-tropic infection was at the level of fusion. For this experiment, we employed a recently developed reporter assay to quantify HIV particle entry [25] . Expanded T CM , T EMRO , and T EMRA cells were infected with either R5.HIV, X4.HIV, or VSV-G.HIV. Fusion of these three viruses with T EMRA cells was similarly efficient, whereas fusion was inhibited in both T N and Jurkat cells, which do not express CCR5, or when cells were pre-treated with T20, a fusion inhibitor ( Figure 7B ). Collectively, these data indicate that the R5.HIV infection block in T EMRA cells is post-fusion.
We next conducted analysis of the stage in the HIV-1 life cycle at which R5-tropic and VSV-G pseudotyped virus replication was blocked in the T EMRA subset. Late reverse transcripts in cells infected with VSV-G.HIV, R5.HIV, and X4.HIV were analyzed. Infection was blocked at the level of reverse transcription in T EMRA cells infected with R5.HIV and VSV-G.HIV, suggesting an early block to infection in these cells that did not affect X4.HIV ( Figure 7C ).
Because we did not see the accumulation of late reverse transcription products, we wanted to understand whether earlier steps in reverse transcription were impaired. Therefore, we investigated the initiation of reverse transcription of R5-tropic and VSV-G pseudotyped virus in T EMRA cells. Early reverse transcription was assessed by the presence of strongstop, minus-strand viral DNA (R/U5 DNA) by quantitative real-time PCR. Early transcripts were not formed in T EMRA cells infected with R5.HIV or VSV-G.HIV ( Figure 7D ). These data suggest that the block in the HIV-1 life cycle occurs at or prior to the initiation of reverse transcription.
Correlation of T EMRA Cell Levels with CD4
þ Cell Numbers in HIV-Infected Individuals Our findings that T EMRA cells are expanded in a portion of HIV-infected individuals and are highly resistant to R5-tropic infection prompted us to examine relationships between high T EMRA cells and CD4 numbers. Among HIV-infected individuals, the T N cell percentage correlated positively with absolute CD4 þ T cell numbers ( Figure 1B) . Conversely, the total T EM cell (T EMRO þ T EMRA ) percentage correlated negatively with CD4 þ T cell numbers ( Figure 1B ; unpublished data). To further delineate the association between T EMRO and T EMRA cell proportions and CD4 numbers, we subdivided infected individuals into three groups based on their total T EM cells (Figure 8 ). Infected individuals in whom the T EM percentage of their CD4 þ T cells was similar to healthy individuals (bottom group) had high CD4 þ cell numbers (Figure 8 ; unpublished data). In contrast, the group with a very high T EM cell percentage had low CD4 þ T cell numbers, and all of these individuals had high levels of T EMRO cells (Figure 8, top group) . Importantly, however, when we subdivided the infected individuals with median levels of T EM cells (Figure 8 , middle group), a highly significant association between higher T EMRA cell percentage and higher CD4 þ T cell numbers and higher T N cells was established Further studies are required to elucidate how T EMRA cells can be resistant to R5-tropic infection despite high levels of CCR5 expression, yet remain susceptible to X4-tropic viruses. In order to exclude that this restriction was at the level of post-entry and not because of downregulation or block of CCR5 by beta-chemokines, we showed that 1) T EMRA cells permitted entry of R5-tropic HIV-1 as measured by the BlaMVpr virion fusion assay, 2) T EMRA cells continued to express high levels of CCR5 at the time of infection, 3) and T EMRA cells were partly less susceptible to VSV-G pseudotyped viruses that bypass the coreceptor requirement. Taken together, these results indicate that the post-entry pathway followed by R5-tropic HIV-1 may differ in T EMRA cells compared to other CD4 þ
CCR5
þ T cell subsets and to X4-tropic HIV-1-infecting T EMRA cells. It is conceivable that either signaling or the entry pathway through the CXCR4 receptor elicits intracellular events needed for HIV replication or bypasses mechanisms that otherwise restrict HIV-1 in T EMRA cells. Elucidating cellular mechanisms that determine why some, but not all, CCR5-expressing CD4 þ T cells are permissive to R5-tropic HIV-1 infection could provide clues to identify Figure 3 . Proliferation, Apoptosis, and Cytokine Profile of CD4 þ T Cell Subsets (A) Sorted CD4 þ T cell subsets from an HIV-uninfected individual were activated using DCs pulsed with SEB (10 ng/ml) and expanded in IL-2-containing medium for 12 d. T cell subsets were then counted to determine fold expansion. (B) Viability of purified CD4 þ T cell subsets was determined using Annexin V staining after 18 h post-activation. Samples were analyzed by flow cytometry. Statistical significance was determined using the Student's two-tailed t test. T N : p ¼ 0.4, T CM : p ¼ 0.002, T EMRO : p ¼ 0.15, and T EMRA :
þ T cell subsets were activated using plate-bound anti-CD3 (3 lg/ml) and soluble anti-CD28 (1 lg/ml) antibodies. Supernatants were collected 18-24 h post-activation and analyzed for cytokine production using the cytometric bead assay. The results show the mean of four different experiments from four different individuals. doi:10.1371/journal.ppat.0030058.g003 [31] . Conferring an HIV-resistant ability to HIV-1-specific CD4 þ T cells could lead to novel strategies aimed at potentiating a protective immune response against HIV-1 infection.
During the primary and asymptomatic phases of HIV-1 infection, R5-tropic viruses predominate, whereas X4-tropic viruses are found in about 50% of infected individuals at late stages of HIV disease [32] [33] [34] . A more rapid decline in total CD4 þ T cell counts is often associated with a switch from R5-tropic to X4-tropic HIV or R5/X4 HIV variants [35] . At present, it is unclear whether the switch to X4-tropic viruses is a cause or a consequence of the collapse of the immune system. Because T EMRA cells remain highly susceptible to X4-tropic viruses, it would be expected that these cells would also be rapidly depleted when an X4-tropic switch occurs. If T EMRA cells contain HIV-specific T cells or play some other protective role against infection, then elimination of these cells by X4-tropic viruses would further weaken the immune response against HIV-1 and facilitate immunological deterioration. In summary, our results demonstrate that CD4 þ T EMRA cells are present at a higher frequency in HIV-infected than uninfected individuals and are resistant to R5-tropic HIV infection, but not to X4-tropic HIV-1 infection. Studies focused on emergence of these effector memory T cell subsets will contribute to a better understanding of HIV-1 pathogenesis and the role of these cells during normal immune responses. Decoding the precise molecular mechanism of the intrinsic resistance of T EMRA cells to R5-tropic infection may have significant implications for developing novel approaches to endow this unique phenotype on HIV-1-susceptible T cells.
Materials and Methods
Cell isolation and culture. PBMCs were separated from blood of HIV-uninfected and HIV-infected individuals through Ficoll-Hypaque (Pharmacia, http://www.pfizer.com). Resting CD4 þ T cells were purified as previously described [22] and were at least 99.5% pure as determined by post-purification FACS analysis. To purify naïve, central, and effector memory subsets, purified CD4 þ cells were stained with CCR7 and CD45RO antibodies, and CD45RO
and CD45RO
À
CCR7
À (T EMRA ) subsets were sorted using the flow cytometer (FACSAria; BD Biosciences, http://www.bdbioscience.com). The culture medium used in all experiments was RPMI (Cellgro, http:// www.cellgro.com) and prepared as described before [22] . All cytokines were purchased from R&D Systems (http://www. rndsystems.com). In some experiments, T EMRO and T EMRA subsets were further subdivided into CD57 þ and CD57 À subsets by flow sorting by staining purified CD4 þ T cells with CCR7, CD45RO, and CD57 antibodies. Monocyte-derived DCs were generated as previously described [22] . The superantigen SEB (Sigma, http://www. sigmaaldrich.com) was used to stimulate resting T cells in the presence of DCs [36] .
Study participants. Uninfected individuals were adults (ages 21-64, mean age was 32) with no history of HIV infection. Whole blood samples from adult participants with HIV infection were obtained during routine primary care visits. Among the HIV-infected individuals, 76% were Caucasian, 82% were male, the median (range) age was 41 (28-59) years, and 79% were receiving potent antiretroviral therapy. Median (IQR) CD4
þ T cell and log 10 plasma HIV-1 RNA values were 380 (270-592) cells/mm 3 and 2.7 (2.6-3.8) copies/ml plasma, respectively, and 50% had fewer than 400 HIV-1 RNA copies/ ml in plasma. There were no selection criteria based on race or sex. All participants provided written informed consent that was approved by the Vanderbilt Institutional Review Board.
Virus production and infections. VSV-G pseudotyped replicationincompetent HIV were generated as previously described [36] . R5-tropic and X4-tropic replication-competent viruses were prepared similarly by transfecting 293T cells with HIV that encodes either R5-tropic (BaL) or X4-tropic (NL4-3) envelope and EGFP (Clontech, http://www.clontech.com) in place of the nef gene as previously described [37] . Wild-type virus (NL4-3) with X4-tropic or with R5-tropic envelope (BaL) and virus (R8) encoding heat stable antigen (HSA) in place of vpr [38] with intact nef gene were obtained from Chris Aiken (Vanderbilt University). Additional viruses used in this study were as follows. NL4-3-based proviral constructs encoding Env genes from R5-tropic proviral 92MW965.26, NL JRFL, NL YU2, and dual-tropic NL89.6 were obtained from Paul Bieniasz (Aaron Diamond AIDS Research Center) and have been previously described [39] . R5-tropic virus JRCSF and X4-tropic virus R9 were obtained from Vineet KewalRamani (National Cancer Institute [NCI]). Typically, viral titers ranged from 1 3 10 6 to 5 3 10 6 IFU/ml for replication-competent viruses and 10 3 10 6 to 30 3 10 6 IFU/ml for VSV-G pseudotyped HIV, as titered on CCR5-expressing Hut78 T cell lines (gift of Vineet KewalRamani, NCI). Viral replication in T cell cultures was determined by measuring p24 levels within supernatants by an ELISA.
T cell apoptosis and cytokine assays. To determine apoptosis, T cells were stimulated with a-CD3 (OKT-3, ATCC)-coated plates in the presence of soluble a-CD28 (1 lg/ml; Pharmingen, http://www. bdbiosciences.com) for 18 h. T cell apoptosis was measured by PEconjugated Annexin V according to manufacturer's instructions (BD Biosciences). Cytokines (IL-2, IL-4, IL-5, IL-10, TNF-a, IFN-c) in the supernatants were assayed using a commercially available cytometric bead assay (CBA) (BD Biosciences) [40] , and analyzed using CBA 6-bead analysis software (BD Biosciences).
FACS analysis. T cells were stained with the relevant antibody on ice for 30 min (chemokine receptor staining performed at room temperature for 20 min) in PBS buffer containing 2% FCS and 0.1% sodium azide. Cells were then washed twice, fixed with 1% paraformaldehyde, and analyzed with a FACSCalibur or FACSAria flow cytometer. Live cells were gated based on forward and side scatter properties, and analysis was performed using FlowJo software (Tree Star, http://www.treestar.com). The following anti-human antibodies were used for staining: CD3, CD4, CD8, CD45RO, CD45RA, CD28, CD27, CD11b, CD57, CD7, CD62L, HLA-DR, CCR5 (all from BD Biosciences), CCR7, and CCR4 (R&D Systems). The CRTH2 antibody used for these experiments has been previously described [41] . Secondary goat-anti-mouse antibodies were conjugated with þ T cell subsets were activated using DCs pulsed with SEB (10 ng/ml) and expanded in IL-2-containing medium for 10 d. (A) Day 12 expanded subsets were stained for CCR5 expression. Cells were then reactivated with SEB-pulsed DCs and subsequently infected with R5.HIV at an MOI of 5. At day 6 post-infection, cells were then stained for CCR5, and infection was analyzed as determined by GFP expression by flow cytometry. (B) R5.HIV, X4.HIV, and VSV-G.HIV carrying a b-lactamase reporter protein were incubated with expanded CD4 þ T cell subsets, T N cells, and Jurkat T cell line at 37 8C for 2 h to allow virus-cell fusion, CCF2/AM (20 lM) was added, and fluorescence was measured as described in Materials and Methods. Fluorescence ratios were calculated after subtraction of the average background fluorescence. (C) Expanded subsets were reactivated with SEB-pulsed DCs and subsequently infected with R5.HIV, X4.HIV, or VSV-G.HIV at an MOI of 5 for 12 h. Cells were then lysed and processed for real-time PCR analysis using late HIV transcript primers. (D) Reactivated expanded T cell subsets were lysed and processed for real-time PCR analysis using early HIV transcript primers. All infections were performed at an MOI of 5. The results are representative of one of five independent experiments using T cell subsets isolated from five different individuals. doi:10.1371/journal.ppat.0030058.g007 Figure 8 . Association between T EM Subsets and CD4 Numbers in HIVInfected Individuals HIV-infected individuals were separated into three groups based on percent of their CD4
þ T EM cells. The medium T EM population was subdivided into T EMRO high T EMRA low and T EMRO low T EMRA high , and the number of total CD4 cells and T N cells in each group was calculated. We set the cut-off percentage for defining T EMRO high and low proportions as 28% of CD4 þ T cells and for T EMRA cells, 8% of CD4 þ T cells. Statistical analysis was performed with only the medium group since the bottom group did not contain any T EMRA high cells (range: 1.6%-5.5%) and within the top group all individuals contained high T EMRO cells (range: 31%-59%). Statistical significance between groups was determined by Wilcoxon rank sum test. doi:10.1371/journal.ppat.0030058.g008 allophycocyanin or PE (BD Biosciences). For the intracellular p24 stain, fixation and permeabilization was performed using a commercial kit (BD Biosciences) according to the manufacturer's instructions. Subsequently, cells were stained with anti-p24 for 1 h, followed by goat-anti-mouse conjugated to allophycocyanin for 30 min.
Virus-cell fusion assay. HIV fusion assays were performed essentially as previously described [25] . Briefly, viruses carrying a blactamase reporter protein fused to the amino terminus of the virion protein Vpr (BlaM-Vpr) were added to expanded T cell subsets at 37 8C for 2 h to allow virus-cell fusion. CCF2/AM (20 lM; Aurora Biosciences Corporation, http://www.vrtx.com) was added, and the cultures were incubated for 14 h at room temperature. Cells were pelleted and resuspended in PBS, and the fluorescence was measured at 447 and 520 nm with a microplate fluorometer after excitation at 409 nm. Uncleaved CCF2 fluoresces green, due to fluorescence resonance energy transfer between the coumarin and fluorescein groups; however, cleavage by BlaM results in the dissociation of these fluorophores, and the emission spectrum shifts to blue. Thus, the ratio of blue to green cellular fluorescence is proportional to the overall extent of virus-cell fusion. Fluorescence ratios were calculated after subtraction of the average background fluorescence of control cultures containing no virus (blue values) and wells containing PBS (green values).
Quantitative analysis of HIV reverse transcription in target cells. Viral DNA was quantified by real-time PCR using an ABI 7700 instrument (PE Biosystems, http://www.appliedbiosystems.com) with SYBR Green chemistry. The reaction mixtures (25 ll total volume) contained 2.5 ll of infected lysate, 12.5 ll of 2x SYBR Green PCR Master Mix (PE Biosystems), and 50 nM of each primer. A standard curve was prepared from serial dilutions of HIV plasmid DNA. The reactions were amplified and analyzed as previously described [42] . The sequences of primers (R and U5) specific for early products were 59-GGCTAACTAGGGAACCCACTGCTT (forward) and 59-CTGCTA-GAGATTTTCCACACTGAC (reverse). The late-product primer sequences (R and 5NC) were 59-TGTGTGCCCGTCTGTTGTGT (forward) and 59-GAGTCCTGCGTCGAGAGAGC (reverse), as previously described.
Statistical analysis. Statistical analyses were performed using Stata version 9.0 (http://www.stata.com). T cell subset and clinical data are presented as means (standard deviation). Statistical significance between groups was determined by Wilcoxon rank sum test. Differences were considered significant at p , 0.05. Figure S1 . CRTH2 Expression on CD4 þ T Cell Subsets Purified CD4 þ T cells were stained with CD45RO and CCR7 in conjunction with the CRTH2 antibody. Electronic gates were set on T N , T CM , T EMRO , and T EMRA cells as described in Figure 1 , and expression of CRTH2 was analyzed by flow cytometry. The results show mean expression from ten different individuals. Found at doi:10.1371/journal.ppat.0030058.sg001 (146 KB TIF). Figure S2 . CCR5 Expression on CD4 þ T Cell Subsets
Supporting Information
PBMCs from HIV-positive individuals were stained with CD4, CD45RO, CCR7, and CCR5 antibodies. Electronic gates were set on CD4 þ T N , T CM , T EMRO , and T EMRA cells as described in Figure 1 , and expression of CCR5 was analyzed by flow cytometry. The results show CCR5 expression from 20 different individuals. The median CCR5 expression levels were: T N ¼ 0.5, T CM ¼ 11.96, T EMRO ¼ 46, and T EMRA ¼ 25.1. Statistical significance was determined for T EMRO and T EMRA versus T CM using the Student's two-tailed t test. * p , 0.05. Found at doi:10.1371/journal.ppat.0030058.sg002 (174 KB TIF).
